More Argent Biopharma Ltd news
Argent Biopharma LtdASX: RGT

MXC Awarded 3-year EU GMP Manufacturing Licence

Jun 23, 2020 at 12:11 AM EDT · Issued by Argent Biopharma Ltd

Filed with ASX · Jun 23, 2020 at 12:11 AM EDT

On 6ix: 6ix.com/news/mxc-awarded-3-year-eu-gmp-manufacturing-licence

Argent Biopharma Limited has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Argent Biopharma Ltd on 6ix

Story so far

  • MXC Awarded GMP Certification & Manufacturing LicenceJul 13, 2018

Earlier from Argent Biopharma

  • Sale of MGC Nutra to US CBD and Hemp Wellness CompanyJun 17, 2020
  • Binding Term Sheet for distribution of CannEpil in IsraelJun 14, 2020
  • 3,250 Prescriptions Milestone SurpassedJun 1, 2020
  • Ethics Committee Approval for CannEpil Phase IIb TrialMay 25, 2020
  • Binding Term Sheet Signed for Distribution of ArtemiCMay 12, 2020

Later from Argent Biopharma

  • COVID-19 Clinical Trial Site Expansion into IndiaJul 2, 2020
  • MGC Pharma awarded Import Licence by Office of Drug ControlJul 7, 2020
  • MXC Cannabis Research Permit Granted for RMIT ProgramsJul 13, 2020
  • MGC Pharma to acquire 100% of Medicinal Cannabis ClinicJul 19, 2020
  • Suspension from Official QuotationJul 24, 2020
All Argent Biopharma news releases↗

Follow Argent Biopharma into a list and get an email when it puts out news.

Follow Argent Biopharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer